raloxifene hydrochloride has been researched along with Hypercholesterolemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ancona, E; Berretta, R; Bertocco, A; Capobianco, G; D'Antona, D; Di Gangi, S; Gizzo, S; Nardelli, GB; Noventa, M; Patrelli, TS; Saccardi, C; Vacilotto, A | 1 |
| Bofilis, E; Iliodromitis, EK; Kremastinos, DT; Kyriakides, ZS; Sbarouni, E | 1 |
| Flevari, P; Koniavitou, K; Kremastinos, DT; Kroupis, C; Kyriakides, ZS; Sbarouni, E | 1 |
| Ciaccia, AV; Davidson, MH; Insull, W; Keech, CA; Kulkarni, PM; Siddhanti, S | 1 |
| Engin-Ustün, Y; Kafkasli, A; Meydanli, MM; Ustün, Y | 1 |
| Hart, W; Netelenbos, JC | 1 |
| Blum, A; Cannon, RO; Csako, G; Hathaway, L; Mincemoyer, R; Panza, JA; Schenke, WH; Waclawiw, MA | 1 |
| Blum, A; Cannon, RO | 1 |
| Dominguez, JE; Shortle, B; Warren, MP | 1 |
4 review(s) available for raloxifene hydrochloride and Hypercholesterolemia
| Article | Year |
|---|---|
Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications.
Topics: Blood Coagulation; Bone and Bones; Breast; Breast Neoplasms; Contraindications; Endometrium; Female; Humans; Hypercholesterolemia; Osteoporosis; Raloxifene Hydrochloride; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators; Thromboembolism | 2013 |
[Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
Topics: Aged; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Hypercholesterolemia; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 1999 |
Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men.
Topics: Animals; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Inflammation; Lipoproteins; Male; Nitric Oxide; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2001 |
Use of alternative therapies in menopause.
Topics: Cardiovascular Diseases; Estrogens; Female; Humans; Hypercholesterolemia; Isoflavones; Lignans; Menopause; Middle Aged; Neoplasms; Osteoporosis, Postmenopausal; Phytotherapy; Plant Preparations; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
4 trial(s) available for raloxifene hydrochloride and Hypercholesterolemia
| Article | Year |
|---|---|
The effects of raloxifene and simvastatin on plasma lipids and endothelium.
Topics: Aged; Cell Adhesion Molecules; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Regional Blood Flow; Selective Estrogen Receptor Modulators; Simvastatin; Vascular Resistance | 2003 |
Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride; Simvastatin | 2005 |
Effects of intranasal 17beta-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: a randomized, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Hypercholesterolemia; Lipids; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2006 |
Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men.
Topics: Cell Adhesion Molecules; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vasodilation | 2000 |
1 other study(ies) available for raloxifene hydrochloride and Hypercholesterolemia
| Article | Year |
|---|---|
Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size.
Topics: Animals; Drug Therapy, Combination; Estrogen Antagonists; Estrogens; Female; Hypercholesterolemia; Medroxyprogesterone; Myocardial Infarction; Necrosis; Ovariectomy; Progesterone Congeners; Rabbits; Raloxifene Hydrochloride | 2003 |